Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity
Copyright policy )Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity
Kidney international 106(5), 856-869 (2024). doi:10.1016/j.kint.2024.08.021
Published by New York, NY, Elsevier
- University of Mary United States
- University of Freiburg Germany
- Aarhus University Denmark
- University Hospital of Lausanne Switzerland
- TU Darmstadt Germany
Mice, Knockout, Polycystic Kidney Diseases, CDK4, Pyridines, bypass mechanism, 610, Cyclin-Dependent Kinase 4, Kinesins, Kidney Diseases, Cystic, Mechanistic Target of Rapamycin Complex 1, Piperazines, Mice, Disease Models, Animal, mTOR pathway, SDG 3 - Good Health and Well-being, Disease Progression, Animals, Humans, Cilia, cystic kidney disease, Protein Kinase Inhibitors, Animals; Humans; Mice; Cilia/pathology; Cilia/metabolism; Cyclin-Dependent Kinase 4/antagonists & inhibitors; Cyclin-Dependent Kinase 4/metabolism; Cyclin-Dependent Kinase 4/genetics; Disease Models, Animal; Disease Progression; Kidney Diseases, Cystic/genetics; Kidney Diseases, Cystic/metabolism; Kidney Diseases, Cystic/pathology; Kidney Diseases, Cystic/drug therapy; Kinesins/genetics; Kinesins/metabolism; Kinesins/antagonists & inhibitors; Mechanistic Target of Rapamycin Complex 1/metabolism; Mechanistic Target of Rapamycin Complex 1/antagonists & inhibitors; Mechanistic Target of Rapamycin Complex 1/genetics; Mice, Knockout; Piperazines/pharmacology; Piperazines/therapeutic use; Polycystic Kidney Diseases/genetics; Polycystic Kidney Diseases/metabolism; Polycystic Kidney Diseases/pathology; Polycystic Kidney Diseases/drug therapy; Protein Kinase Inhibitors/pharmacology; Protein Kinase Inhibitors/therapeutic use; Pyridines/pharmacology; Pyridines/therapeutic use; Signal Transduction; CDK4; bypass mechanism; cystic kidney disease; mTOR pathway, Signal Transduction
Mice, Knockout, Polycystic Kidney Diseases, CDK4, Pyridines, bypass mechanism, 610, Cyclin-Dependent Kinase 4, Kinesins, Kidney Diseases, Cystic, Mechanistic Target of Rapamycin Complex 1, Piperazines, Mice, Disease Models, Animal, mTOR pathway, SDG 3 - Good Health and Well-being, Disease Progression, Animals, Humans, Cilia, cystic kidney disease, Protein Kinase Inhibitors, Animals; Humans; Mice; Cilia/pathology; Cilia/metabolism; Cyclin-Dependent Kinase 4/antagonists & inhibitors; Cyclin-Dependent Kinase 4/metabolism; Cyclin-Dependent Kinase 4/genetics; Disease Models, Animal; Disease Progression; Kidney Diseases, Cystic/genetics; Kidney Diseases, Cystic/metabolism; Kidney Diseases, Cystic/pathology; Kidney Diseases, Cystic/drug therapy; Kinesins/genetics; Kinesins/metabolism; Kinesins/antagonists & inhibitors; Mechanistic Target of Rapamycin Complex 1/metabolism; Mechanistic Target of Rapamycin Complex 1/antagonists & inhibitors; Mechanistic Target of Rapamycin Complex 1/genetics; Mice, Knockout; Piperazines/pharmacology; Piperazines/therapeutic use; Polycystic Kidney Diseases/genetics; Polycystic Kidney Diseases/metabolism; Polycystic Kidney Diseases/pathology; Polycystic Kidney Diseases/drug therapy; Protein Kinase Inhibitors/pharmacology; Protein Kinase Inhibitors/therapeutic use; Pyridines/pharmacology; Pyridines/therapeutic use; Signal Transduction; CDK4; bypass mechanism; cystic kidney disease; mTOR pathway, Signal Transduction
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).1 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!